EPIX

ESSA PHARMA INC

1 day chart

About EPIX

ESSA Pharma Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is focused on developing proprietary therapies for the treatment of patients with prostate cancer. Its lead candidate, EPI-7386, is an oral, small molecule that inhibits the N-terminal domain of the androgen receptor (AR). The Company is completing the initial Phase I clinical development of EPI-7386 as a monotherapy treatment for patients with metastatic castration-resistant prostate cancer (mCRPC). The Company is also developing ANITen bAsed Chimera (ANITAC) AR NTD degraders to suppress androgen biology.

Buy US stocks in Australia starting with EPIX. Open an account and start investing today!

Market Capitalisation

$134.51M

Price-earnings ratio

Dividend yield

0.00%

Volume

49.77K

High today

$3.14

Low today

$2.95

Open price

$3.00

52-week high

$5.16

52-week low

$1.40

EPIX FAQs

Can I buy EPIX shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?

Yes, the Stake platform allows you to buy EPIX shares and over 8,000 stocks and ETFs across the ASX and Wall St.

How much is one share of ESSA PHARMA INC?

One share of ESSA PHARMA INC is valued at $2.68.

What is the ticker symbol for ESSA PHARMA INC?

The ticker symbol for ESSA PHARMA INC is EPIX.

How do I buy EPIX shares in Australia?

To buy EPIX stocks in Australia you'll need to open an account with an investing platform like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake Wall St
Deposit directly into your Stake wallet and you're ready to invest in EPIX

What is the 52-week high for ESSA PHARMA INC stock?

The ESSA PHARMA INC 52-week high stock price is $5.16.

What is the 52-week low for ESSA PHARMA INC stock?

The ESSA PHARMA INC 52-week low stock price is $1.40.

What is the market capitalisation of ESSA PHARMA INC EPIX?

As of 30/09/2023 ESSA PHARMA INC has a market cap of $135M.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.